Search - tctmd.com

Displaying 121 - 140 of 198

Sort: Relevancy | Date

Presentation NY Valves 2024

Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar M. Abdelfattah

June 07, 2024

Presentation NY Valves 2024

Clinical Outcomes According to Aortic Stenosis Management: Insights From Real-World Practice

Presenter: Augustin Coisne

June 07, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Access Disparities Affecting Appropriate AS Therapy

Presenter: David A. Wood

June 07, 2024

Presentation NY Valves 2024

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Presenter: Brian R. Lindman

June 07, 2024

Presentation NY Valves 2024

Noninvasive Finger Cuff Screening for Aortic Valve Stenosis Using Artificial Intelligence

Presenter: Joseph Kassab

June 07, 2024

Presentation NY Valves 2024

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Presenter: Michael J. Reardon

June 07, 2024

Presentation NY Valves 2024

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

Presenter: Robert L. Smith, Megan Coylewright

June 07, 2024

Presentation NY Valves 2024

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Early vs Delayed Intervention for Aortic Stenosis: A Patient’s Perspective

Presenter: Megan Coylewright

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

How Standard and Novel Imaging Can Help Determine the Optimal Timing of AS Intervention

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

The Rationale for Earlier Intervention in Aortic Stenosis

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

Presentation NY Valves 2024

Metanalysis of Clinical and Hemodynamic Differences in Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus

Presenter: Errol Christopher Moras

June 06, 2024

Presentation NY Valves 2024

Female Sex Is Not Associated With Increased Vascular Afterload in Older Patients With Aortic Stenosis

Presenter: Sara Hungerford

June 06, 2024

Presentation NY Valves 2024

Invasive Exercise Hemodynamics in Aortic Stenosis

Presenter: Abdullah Al-Abcha

June 06, 2024

Presentation NY Valves 2024

Clinical Characteristics and Outcomes of High Gradient Aortic Stenosis Undergoing TAVR

Presenter: Shivabalan Kathavarayan Ramu

June 06, 2024

Presentation NY Valves 2024

Predictors of Mortality Following Transcatheter Aortic Valve Replacement in Patients With Classical Low-Flow Low-Gradient Severe Aortic Stenosis

Presenter: Besir Besir

June 06, 2024

Advertisement

Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data

Clinical Outcomes According to Aortic Stenosis Management: Insights From Real-World Practice

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Access Disparities Affecting Appropriate AS Therapy

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Noninvasive Finger Cuff Screening for Aortic Valve Stenosis Using Artificial Intelligence

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Early vs Delayed Intervention for Aortic Stenosis: A Patient’s Perspective

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

How Standard and Novel Imaging Can Help Determine the Optimal Timing of AS Intervention

The Rationale for Earlier Intervention in Aortic Stenosis

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Metanalysis of Clinical and Hemodynamic Differences in Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus

Female Sex Is Not Associated With Increased Vascular Afterload in Older Patients With Aortic Stenosis

Invasive Exercise Hemodynamics in Aortic Stenosis

Clinical Characteristics and Outcomes of High Gradient Aortic Stenosis Undergoing TAVR

Predictors of Mortality Following Transcatheter Aortic Valve Replacement in Patients With Classical Low-Flow Low-Gradient Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content